주메뉴
메인비쥬얼
Group Introduction
메인 컨텐츠
News
Total 83, 8/9 Page
| Number | Title | Date | Read |
|---|---|---|---|
| 13 | Huons Accelerates Biopharmaceutical Development with Human-Derive.. | 2024-11-08 | 2338 |
| 12 | Huons Achieves `A` in 2024 ESG Comprehensive Assessment | 2024-10-30 | 1769 |
| 11 | Huons Meditech Accelerates Overseas Marketing | 2024-10-29 | 2884 |
| 10 | Huonslab Announces Positive Results from Non-Clinical PK Comparat.. | 2024-09-04 | 2324 |
| 9 | Huonslab Receives IND Approval from MFDS to Start Pivotal Clinica.. | 2024-08-07 | 3294 |
| 8 | Huons Meditech Showcases Key Products at FIME 2024 in Florida | 2024-06-25 | 3759 |
| 7 | Huons Meditech Targets South American Market at `Hospitalar 2024`.. | 2024-05-27 | 2979 |
| 6 | “Huonslab Completes IND Submission for Recombinant Human Hyalur.. | 2024-04-29 | 5144 |
| 5 | Huons Meditech wins `$7 million Export Tower awards` | 2023-12-07 | 3431 |
| 4 | Huonslab Confirms Recombinant Human Hyaluronidase Effectiveness | 2023-10-24 | 3827 |
푸터
Name: Huons Global|President: Sungtae Yoon, Sooyoung Song
Address: 9th Floor HuonsGlobal Bldg., A-dong Pangyo I-Square, 17, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
TEL: 02)854-4700|FAX: 02)6455-0740|Customer Service: 080-447-4700|Corporate Registration Number: 129-81-07002
COPYRIGHT Huons Global ALL RIGHTS RESERVED. DESINGED BY SINBIWEB